Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of the clinical stage of type 1 diabetes and to manage the underlying autoimmunity beginning at the time-at-onset and onwards. Initial phase I trials demonstrated that the admin...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Revisão |
| Idioma: | anglès |
| Publicat: |
2019
|
| Accés en línia: | https://doi.org/10.3389/fimmu.2019.00148 https://www.frontiersin.org/articles/10.3389/fimmu.2019.00148/pdf |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|